Ginsenoside-Re ameliorates ischemia and reperfusion injury in the heart: A hemodynamics approach

Journal of Ginseng Research

Volumn 37, Issue 3, 2013, Pages 283-292

  Lim, Kyu Hee ^a   Lim, Dae Jun ^b   Kim, Jong Hoon ^a  

^a Chonbuk National University   (South Korea)

^b Konkuk University   (South Korea)

Author keywords

Cardiac injury; Ginsenoside Re; Hemodynamics; Myocardial preservation; Panax ginseng

Indexed keywords

EID: 84880074166     PISSN: 12268453     EISSN: None     Source Type: Journal    
DOI: 10.5142/jgr.2013.37.283     Document Type: Article

References (34)

1. Ostadal B. The past, the present and the future of experimental research on myocardial ischemia and protection. Pharmacol Rep 2009;61:3-12.
2. Gross GJ, Kersten JR, Warltier DC. Mechanisms of postischemic contractile dysfunction. Ann Thorac Surg 1999;68:1898-1904.
3. Piper HM, Garcia-Dorado D. Prime causes of rapid car-diomyocyte death during reperfusion. Ann Thorac Surg 1999;68:1913-1919.
4. Verma S, Fedak PW, Weisel RD, Butany J, Rao V, Mai-tland A, Li RK, Dhillon B, Yau TM. Fundamentals of reperfusion injury for the clinical cardiologist. Circulation 2002;105:2332-2336.
5. Fleming PR. A short history of cardiology. Amsterdam: Rodopi Publishers, 1997.
6. Rodriguez-Sinovas A, Abdallah Y, Piper HM, Garcia-Dorado D. Reperfusion injury as a therapeutic challenge in patients with acute myocardial infarction. Heart Fail Rev 2007;12:207-216.
7. Buja LM. Myocardial ischemia and reperfusion injury. Cardiovasc Pathol 2005;14:170-175.
8. Kim JH. Cardiovascular diseases and Panax ginseng: a review on molecular mechanisms and medical applications. J Ginseng Res 2012;36:16-26.
9. Murphy E, Steenbergen C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev 2008;88:581-609.
10. Hardoon SL, Whincup PH, Lennon LT, Wannamethee SG, Capewell S, Morris RW. How much of the recent decline in the incidence of myocardial infarction in British men can be explained by changes in cardiovascular risk factors? Evidence from a prospective population-based study. Circulation 2008;117:598-604.
11. Heidenreich PA, McClellan M. Trends in treatment and outcomes for acute myocardial infarction: 1975-1995. Am J Med 2001;110:165-174.
12. Luepker RV. Decline in incident coronary heart disease: why are the rates falling? Circulation 2008;117:592-593.
13. Peng DC, Chen WP, Xie JT. Antihyperglycemic effects of ginseng and possible mechanisms. Drugs Future 2008;33:507-514.
14. Chevallier A. Encyclopedia of herbal medicine. New York: DK Publishing, 2000.
15. Park YH, Kim YC, Park SU, Lim HS, Kim JB, Cho BK, Bae H. Age-dependent distribution of fungal endophytes in Panax ginseng roots cultivated in Korea. J Ginseng 2012;36:327-333.
16. Blumenthal M, Goldberg A, Brinckmann J, Foster S, Tyler VE. Ginseng root. Newton: Integrative Medicine Communications, 2000.
17. Barnes PM, Powell-Griner E, McFann K, Nahin RL. Complementary and alternative medicine use among adults: United States, 2002. Adv Data 2004;(343):1-19.
18. Lee SJ, Sung JH, Lee SJ, Moon CK, Lee BH. Antitumor activity of a novel ginseng saponin metabolite in human pulmonary adenocarcinoma cells resistant to cisplatin. Cancer Lett 1999;144:39-43.
19. Baek SH, Bae ON, Park JH. Recent methodology in ginseng analysis. J Ginseng 2012;36:119-134.
20. Shi Y, Sun C, Zheng B, Li Y, Wang Y. Simultaneous determination of nine ginsenosides in functional foods by high performance liquid chromatography with diode array detector detection. Food Chem 2010;123:1322-1327.
21. Gillis CN. Panax ginseng pharmacology: a nitric oxide link? Biochem 1997;54:1-8.
22. Kim DH. Chemical diversity of Panax ginseng, Panax quinquifolium, and Panax notoginseng. J Ginseng Res 2012;36:1-15.
23. Xie JT, Mehendale SR, Li X, Quigg R, Wang X, Wang CZ, Wu JA, Aung HH, A Rue P, Bell GI et al. Anti-diabetic effect of ginsenoside Re in ob/ob mice. Biochim Biophys Acta 2005;1740:319-325.
24. Xie JT, Shao ZH, Vanden Hoek TL, Chang WT, Li J, Me-hendale S, Wang CZ, Hsu CW, Becker LB, Yin JJ et al. Antioxidant effects of ginsenoside Re in cardiomyocytes. Eur J Pharmacol 2006;532:201-207.
25. Peng L, Sun S, Xie LH, Wicks SM, Xie JT. Ginsenoside Re: pharmacological effects on cardiovascular system. Cardiovasc Ther 2012;30:e183-e188.
26. Minematsu T, Ohtani H, Yamada Y, Sawada Y, Sato H, Iga T. Quantitative relationship between myocardial concentration of tacrolimus and QT prolongation in guinea pigs: pharmacokinetic/pharmacodynamic model incorporating a site of adverse effect. J Pharmacokinet Pharmaco-dyn 2001;28:533-554.
27. Ohtani H, Hanada E, Yamamoto K, Sawada Y, Iga T. Pharmacokinetic-pharmacodynamic analysis of the elec-trocardiographic effects of terfenadine and quinidine in rats. Biol Pharm Bull 1996;19:1189-1196.
28. Song SB, Tung NH, Quang TH, Ngan NT, Kim KE, Kim YH. Inhibition of TNF-α-mediated NF-κB transcriptional activity in HepG2 cells by dammarane-type saponins from Panax ginseng leaves. J Ginseng Res 2012;36:146-152.
29. Yang Y, Hu SJ, Li L, Chen GP. Cardioprotection by poly-saccharide sulfate against ischemia/reperfusion injury in isolated rat hearts. Acta Pharmacol Sin 2009;30:54-60.
30. Peng Y, Sun Z. Characterization of QT and RR interval series during acute myocardial ischemia by means of recurrence quantifcation analysis. Med Biol Eng Comput 2011;49:25-31.
31. Bak I, Lekli I, Juhasz B, Nagy N, Varga E, Varadi J, Gesz-telyi R, Szabo G, Szendrei L Bacskay I et al. Cardiopro-tective mechanisms of Prunus cerasus (sour cherry) seed extract against ischemia-reperfusion-induced damage in isolated rat hearts. Am J Physiol Heart Circ Physiol 2006;291:1329-1336.
32. Hearse DJ, Sutherland FJ. Experimental models for the study of cardiovascular function and disease. Pharmacol Res 2000;41:597-603.
33. Patel V, Upaganlawar A, Zalawadia R, Balaraman R. Cardioprotective effect of melatonin against isoproterenol induced myocardial infarction in rats: a biochemical, elec-trocardiographic and histoarchitectural evaluation. Eur J Pharmacol 2010;644:160-168.
34. Ramani R, Mathier M, Wang P, Gibson G, Togel S, Daw-son J, Bauer A, Alber S, Watkins SC, McTiernan CF et al. Inhibition of tumor necrosis factor receptor-1-mediated pathways has benefcial effects in a murine model of post-ischemic remodeling. Am J Physiol Heart Circ Physiol 2004;287:H1369-H1377.